Domain Therapeutics

📍 Illkirch-Graffenstaden, France🗓 Founded 2008👥 86 employees💰 Last funded May 2022
Pharmaceutical Manufacturing🌐 domaintherapeutics.com
Website LinkedIn
Domain Therapeutics, a clinical-stage global biopharmaceutical company, focused on developing innovative immunotherapies targeting G Protein-Coupled Receptors (GPCRs), one of the most important drug target classes, to unlock new possibilities in cancer. As a leader in GPCRs in immuno-oncology, Domain sees cancer differently, using a precise biomarker strategy to address the specific needs of patients based on unique signatures of individual cancers. Two decades of solid experience in GPCR drug discovery, validated by multiple pharma partnerships, associated to a target identification and drug discovery platform enable the Company to enhance the understanding of cancer and deliver innovative immunotherapies to patients. Domain’s proprietary programs include DT-7012, a Treg-depleting CCR8 antibody, DT-9045, a first-in-class PAR2 negative allosteric modulator, and DT-9081, an EP4 receptor antagonist alongside the M1069, an A2aR/A2b receptor antagonist identified in partnership with Merck KGaA. The company has also an optimized pipeline of best-in-class and first-in-class GPCR targets selected through Domain’s proprietary cross-validation drug discovery and development platform.
3
Total investors
0
Early stage
1
Mid stage
0
Late stage
2008
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Canada
2
France
1
Investor activity2012–2022 · investors recorded per year
2012120222
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Domain Therapeutics?
Domain Therapeutics has 3 investors on record on gritt.io, 1 mid-stage.
When did Domain Therapeutics last raise funding?
The most recent investment in Domain Therapeutics recorded on gritt.io was in May 2022.
When was Domain Therapeutics founded?
Domain Therapeutics was founded in 2008.
What industry is Domain Therapeutics in?
Domain Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Domain Therapeutics based?
Domain Therapeutics is headquartered in Illkirch-Graffenstaden, France.